SHENZHEN XINCHANGXIANG TECHNOLOGY CO., LTD. – Trademark Portfolio
Entity Type: 99
SHENZHEN XINCHANGXIANG TECHNOLOGY CO., LTD. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 18 (Leather Goods) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include RQH. The owner is based in SHENZHEN.
507, UNIT 2, BLDG B, BAOXIN GARDEN
NO. 362, BAOXIN RD., XIN'AN ST., BAO'AN DIST.,
SHENZHEN 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
SHENZHEN XINCHANGXIANG TECHNOLOGY CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does SHENZHEN XINCHANGXIANG TECHNOLOGY CO., LTD. have?
SHENZHEN XINCHANGXIANG TECHNOLOGY CO., LTD. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does SHENZHEN XINCHANGXIANG TECHNOLOGY CO., LTD. file in?
SHENZHEN XINCHANGXIANG TECHNOLOGY CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 18 (Leather Goods), Class 10 (Medical Apparatus). Class 18 covers leather and imitations of leather; animal skins, hides; trunks and travelling bags.
What are SHENZHEN XINCHANGXIANG TECHNOLOGY CO., LTD.'s most well-known trademarks?
SHENZHEN XINCHANGXIANG TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as RQH. These are among 2 currently registered trademarks in the portfolio.
What is SHENZHEN XINCHANGXIANG TECHNOLOGY CO., LTD.'s trademark registration success rate?
SHENZHEN XINCHANGXIANG TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.